Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration
机构:[1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Beijing Retinal and Choroidal Vascular Disorders Study Group, Beijing, China.[3]Division of Medical Affairs, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.[4]Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences & School of Basic Medicine Peking Union Medical College, Beijing, China.
the National Natural Science
Foundation of China [Grant 81570850 and 82070988] and the
Ministry of Science and Technology Foundation of China
[Grant 2016YFC1305604]
第一作者机构:[1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[2]Beijing Retinal and Choroidal Vascular Disorders Study Group, Beijing, China.
共同第一作者:
通讯作者:
通讯机构:[1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[2]Beijing Retinal and Choroidal Vascular Disorders Study Group, Beijing, China.
推荐引用方式(GB/T 7714):
Zhang Xinyuan,Qiu Bingjie,Gong Zhizhong,et al.Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration[J].FRONTIERS IN ENDOCRINOLOGY.2022,13:946327.doi:10.3389/fendo.2022.946327.
APA:
Zhang Xinyuan,Qiu Bingjie,Gong Zhizhong,Chen Xiaosi,Wang Yanhong&Nie Yao.(2022).Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration.FRONTIERS IN ENDOCRINOLOGY,13,
MLA:
Zhang Xinyuan,et al."Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration".FRONTIERS IN ENDOCRINOLOGY 13.(2022):946327